Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10006324HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10003145HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10022102HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10025984HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10051965HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS10052093HBVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS30025272HIVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TVIS30025273HIVENSG00000160752.15protein_codingFDPSNoNo2224A0A087X090
P14324
TCGA Plot Options
Drug Information
GeneFDPS
DrugBank IDDB00399
Drug NameZoledronic acid
Target IDBE0000776
UniProt IDP14324
Regulation Typeinhibitor
PubMed IDs11160603; 17477829; 17535895; 11752352
CitationsDunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ: Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther. 2001 Feb;296(2):235-42.@@Glickman JF, Schmid A: Farnesyl pyrophosphate synthase: real-time kinetics and inhibition by nitrogen-containing bisphosphonates in a scintillation assay. Assay Drug Dev Technol. 2007 Apr;5(2):205-14.@@Guo RT, Cao R, Liang PH, Ko TP, Chang TH, Hudock MP, Jeng WY, Chen CK, Zhang Y, Song Y, Kuo CJ, Yin F, Oldfield E, Wang AH: Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10022-7. Epub 2007 May 29.@@Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.
GroupsApproved
Direct ClassificationBisphosphonates
SMILESOC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O
PathwaysZoledronate Action Pathway
PharmGKBPA10235
ChEMBLCHEMBL924